U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951685) titled 'Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study' on April 11.
Brief Summary: A prospective, single arm, non-randomized early feasibility study to evaluate the preliminary safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective above-knee femoral popliteal bypass surgery.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Peripheral Artery Occlusive Disease
Intervention:
DEVICE: Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit
The XPAD bypass conduit is a sterile, restorative biodegradable polymer-b...